Skip to content

CYRUSONE INC.

CIK 0001553023

← back to feed
Revenue (TTM)
$1.15B
+16.7% YoY FY Mar 2022
Net Income (TTM)
−$5M
−38.9% YoY FY Mar 2022
EPS Diluted (TTM)
−$0.06
−42.9% YoY FY Mar 2022
Gross Margin
56.5%
FY Mar 2022
Operating Margin
3.2%
FY Mar 2022
Net Margin
-0.4%
FY Mar 2022
Free Cash Flow (TTM)
$98.8M
FY Mar 2022
Cash
$346.3M
FY Mar 2022
Total Debt
$3.49B
FY Mar 2022
Shares Outstanding
131.15M sh
FY Mar 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings